🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Changes in microbiome have been reported recently in psoriasis lesions comp...
Status
Completed
Location
CHU de Nice
Start Date
2018-09-24
Trial ID
NCT03584360
Evaluation of efficacy and safety of Mapracorat 0.1% ointment and 4 compara...
Status
Completed
Location
Multiple Locations
Start Date
2013-02-11
Trial ID
NCT03399526
Vasoconstriction study with LEO 90100...
Status
Completed
Location
CPCAD
Start Date
2016-12
Trial ID
NCT02973776
Treatments Being Tested
Psoriasis affects 2-4% of the Western adult population and is a socio-econo...
Status
Completed
Location
Department of Dermatology and Allergy Centre
Start Date
2020-06-19
Trial ID
NCT04220554
Treatments Being Tested
The purpose of the study is to investigate if combined use of OLUX-E™ Foam ...
Status
Completed
Location
DermResearch, PLLC
Start Date
2013-01
Trial ID
NCT01745133
Treatments Being Tested
A multi-center, randomized, single blind, positive controlled trials that a...
Status
Completed
Location
Multiple Locations
Start Date
2015-04
Trial ID
NCT02733874
Treatments Being Tested
Evaluate the efficacy of Clobex® Spray as compared to Taclonex® Ointment in...
Status
Completed
Location
Minnesota Clinical Study Center
Start Date
2006-08
Trial ID
NCT00437255
Treatments Being Tested
To estimate the difference in effectiveness between treatment with etanerce...
Status
Completed
Location
Research Site
Start Date
2011-04
Trial ID
NCT01313221
Treatments Being Tested
The purpose of this trial is to compare the anti-psoriatic effect of a topi...
Status
Completed
Location
LEO Pharma investigational site
Start Date
2010-01
Trial ID
NCT01043224
The objective of this trial is to compare the vasoconstriction potential...
Status
Completed
Location
CPCAD
Start Date
2018-11-05
Trial ID
NCT03758365